A Study to Describe the Safety and Effectiveness of Venetoclax in Acute Myeloid Leukemia (AML) Patients (REVIVE Study)
A Study to Describe the Safety and Effectiveness of Venetoclax in Acute Myeloid Leukemia (AML) Patients (REVIVE Study)
Active, not recruiting · NCT03987958 · Registry updated 2026-01-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Describe the Safety and Effectiveness of Venetoclax in Acute Myeloid Leukemia (AML) Patients (REVIVE Study) | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Active, not recruiting | Not stated | 2026-01-16 | NCT03987958 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AbbVie | 340 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Assuta Tel Aviv Medical Center /ID# 213371 | Tel Aviv | Israel | 1 |
| Bnai Zion Medical Center /ID# 213344 | Haifa | Israel | 1 |
| Hadassah /ID# 213356 | Jerusalem | Israel | 1 |
| HaEmek Medical Center /ID# 213370 | Afula | Israel | 1 |
| Meir Medical Center /ID# 213352 | Kfar Saba | Israel | 1 |
| Rabin Medical Center. /ID# 213343 | Petah Tikva | Israel | 1 |
| Rambam Health Care Campus /ID# 213355 | Haifa | Israel | 1 |
| Shaare Zedek Medical Center /ID# 228016 | Jerusalem | Israel | 1 |
| Soroka University Medical Center /ID# 213369 | Beersheba | Israel | 1 |
| Tel Aviv Sourasky Medical Center /ID# 213354 | Tel Aviv | Israel | 1 |
| The Chaim Sheba Medical Center /ID# 213353 | Ramat Gan | Israel | 1 |
| ZIV Medical Center /ID# 229211 | Safed | Israel | 1 |